Our Company

1-10 of 57

Open vs. minimally invasive hysterectomy: Commercially insured costs and readmissions22 August 2016 - By Andrew Bochner and Kathryn V. Fitch and Warner Huh - Article

This paper analyzes commercial payer differences in the average costs and readmission rates between inpatient open hysterectomies and three types of outpatient hysterectomies: laparoscopic, laparoscopic assisted, and vaginal.

Cardiovascular event incidence and cost in type 2 diabetes: A commercial and Medicare claim based actuarial analysis10 August 2016 - By Helen E. Blumen and Kathryn V. Fitch and Tyler Engel - Article

An analysis to identify the annual rate and cost of cardiovascular (CV) events in patients with type 2 diabetes mellitus (T2DM) and the contribution of these CV events to both T2DM annual costs as well as total Medicare fee-for-service and commercially insured population annual costs.

Cost differences between open and minimally invasive surgery06 August 2016 - By Andrew Bochner and Kathryn V. Fitch and Tyler Engel - Article

This study analyzes the difference in payer costs between minimally invasive surgery and open surgery in a commercial population for four commonly performed elective surgical procedures.

Short term disability claims following lumbar spinal stenosis surgery: An analysis of employer costs26 April 2016 - By Kathryn V. Fitch and Tyler Engel - Article

This client report analyzes the short term disability (STD) claim experience of those with disability eligibility to determine if there was a notable difference in STD initiation and duration between spinal surgery patients who had decompression and those who had decompression with lumbar.

Cost drivers of cancer care: A retrospective analysis of Medicare and commercially insured population claim data 2004-201414 April 2016 - By Bruce S. Pyenson and Kathryn V. Fitch and Pamela M. Pelizzari - Article
This report identifies trends in the overall and component costs of cancer care, creates comparisons to cost trends in the non-cancer population, and identifies several drivers influencing the rising cost of cancer care.Comparison of treatment costs for breast cancer, by tumor stage and type of service18 February 2016 - By Helen E. Blumen and Kathryn V. Fitch and Vincent Polkus - Article

The diagnosis of breast cancer at early stages is associated with better clinical and survival outcomes. But how the costs of care vary depending on the stage at which the disease was diagnosed have not been thoroughly examined.

Longitudinal commercial claims–based cost analysis of diabetic retinopathy screening patterns19 October 2015 - By Adam Turpcu and Helen E. Blumen and Kathryn V. Fitch and Purav Dave and Thomas Weisman and Tyler Engel and Yamina Rajput - Article

An analysis of the relationship between the frequency of retinopathy screening and the cost of care in adult patients with diabetes.

Utilization and cost of surgery for lumbar spinal stenosis in a commercially insured population13 October 2015 - By Helen E. Blumen and Kathryn V. Fitch and Tyler Engel - Article

An analysis of the frequency and cost of lumbar spinal stenosis-related decompression and lumbar fusion surgeries in a commercially insured population.

The high cost of heart failure for health systems: Opportunities for better management22 July 2015 - By Bruce S. Pyenson and Kathryn V. Fitch and Tyler Engel - Article

This report details the utilization and cost of Medicare heart failure (HF) patients at the level of metropolitan statistical areas.

The high cost of heart failure for the Medicare population: An actuarial cost analysis04 February 2015 - By Bruce S. Pyenson and Kathryn V. Fitch and Pamela M. Pelizzari - Article

Heart failure is becoming increasingly prevalent in the U.S., with its total direct medical cost expected to be $53.1 billion by 2030.


  • Work at Milliman

    • “I was offered a chance to come in, shake things up, create something."
    Work at Milliman